The novel bacteriophage could eventually open up new ways to detect, treat or decontaminate the anthrax bacillus and its relatives that cause food poisoning.
From a zebra carcass on the plains of Namibia in Southern Africa, an international team of researchers has discovered a new, unusually large virus (or bacteriophage) that infects the bacterium that causes anthrax. The novel bacteriophage could eventually open up new ways to detect, treat or decontaminate the anthrax bacillus and its relatives that cause food poisoning. The work is published Jan. 27 in the journal PLOS One.
The virus was isolated from samples collected from carcasses of zebras that died of anthrax in Etosha National Park, Namibia. The anthrax bacterium, Bacillus anthracis, forms spores that survive in soil for long periods. Zebras are infected when they pick up the spores while grazing; the bacteria multiply and when the animal dies, they form spores that return to the soil as the carcass decomposes.
While anthrax is caused by a bacterium that invades and kills its animal host, bacteriophages, literally “bacteria eaters” are viruses that invade and kill bacterial hosts.
The first thing the team noticed was that the virus was a voracious predator of the anthrax bacterium, said Holly Ganz, a research scientist at the UC Davis Genome Center and first author on the paper.
They also noticed that the new virus, named Bacillus phage Tsamsa, is unusually large, with a giant head, a long tail and a large genome, placing it among the largest known bacteriophages.
Tsamsa infects not only B. anthracis but also some closely related bacteria, including strains of Bacillus cereus, which can cause food poisoning. Sequencing the genome allowed researchers to identify the gene for lysin, an enzyme that the virus uses to kill bacterial cells, that has potential use as an antibiotic or disinfecting agent.
Bacteriophages are often highly specific to a particular strain of bacteria, and when they were first discovered in the early 20th century there was strong interest in them as antimicrobial agents. But the discovery of penicillin and other antibiotics eclipsed phage treatments in the West, although research continued in the Soviet Union.
“With growing concerns about antibiotic resistance and superbugs, people are coming back to look at phages,” said Ganz said.
One advantage of bacteriophages is that because they tend to be very specific, they can potentially target only “bad” bacteria while leaving beneficial bacteria unharmed. Also, phages evolve with the host and have the potential to overcome bacterial resistance, said coauthor Jochen Klumpp of the Institute of Food, Nutrition and Health, ETH Zurich.
Ganz began the work as a postdoctoral scientist on a team led by Wayne Getz, Professor of Environmental Science, Policy and Management at UC Berkeley and at the University of KwaZulu-Natal, South Africa. Sequencing of the phage genome was conducted at UC Davis after Ganz joined the laboratory of Professor Jonathan Eisen.
Ganz said that she hoped the publication of the phage’s sequence information would enable other researchers to investigate further and potentially develop applications for the phage and its proteins.
“You might use it to detect the anthrax bacillus or B. cereus; use it as an alternative to antibiotics or as part of a decontaminant,” she said.
The Latest on: Phage treatments
[google_news title=”” keyword=”Phage treatments” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Phage treatments
- When Giants Fight Microscopic Wars: Jumbo Viruses Tackle Superbugson May 11, 2024 at 11:30 pm
In the early 20th century, antibiotics gained widespread recognition as an effective treatment for bacterial infections. In what is deemed as the antibiotic golden age, they were regularly developed ...
- Buy Rating Affirmed for Armata Pharmaceuticals Amid Progress and Strategic Financial Moveson May 8, 2024 at 3:26 am
H.C. Wainwright analyst Joseph Pantginis maintained a Buy rating on Armata Pharmaceuticals (ARMP – Research Report) today and set a price ...
- Bacteriophages articles from across Nature Portfolioon May 5, 2024 at 5:00 pm
coli O157 clinical isolates and suggesting broad applications in bacterial detection and phage therapy. SAR11 bacteria and their phages are abundant in the oceans. Here the authors quantify the ...
- Cytophage To Focus On Commercialization Efforts In 2024on April 30, 2024 at 7:13 am
Cytophage Technologies (TSXV: CYTO) has filed its fiscal 2023 results, providing a recap on a successful year in terms of corporate development while providing an outline of where the company is ...
- Cytophage Announces Fiscal Year End 2023 Resultson April 30, 2024 at 5:32 am
Cytophage is the first phage company to provide phage therapy in Canada for a prosthetic joint infection. Construction started on its new 20,000 sq ft facility that will include a state-of-the-art ...
- Phage Therapies for Multidrug-Resistant Infections Should Consider Host Responseon April 22, 2024 at 4:59 pm
One study estimates that bacterial antimicrobial resistance was responsible for 1.27 million global deaths in 2019. Phage therapy (also known as bacteriophage therapy), which relies on the use of ...
- BiomX Announces the Appointment of Susan Blum to its Board of Directorson April 18, 2024 at 1:00 am
BiomX is a clinical-stage company developing both natural and engineered phage cocktails and personalized phage treatments designed to target and destroy bacteria in the treatment of chronic diseases.
- Phage Cocktails and the Future of Phage Therapyon April 17, 2024 at 5:00 pm
Given these issues, phage treatment will probably attain a foothold in western medicine particularly where its use can prevent large medical costs. Therefore, over the next 5–10 years ...
- Researchers resolve old mystery of how phages disarm pathogenic bacteriaon April 14, 2024 at 5:00 pm
The prevalence of antibiotic-resistant Pseudomonas infections makes them a practical point of focus for phage therapy, a type of treatment method using bacteriophages, or phages, that researchers ...
- Phage Cocktails and the Future of Phage Therapyon April 12, 2024 at 5:00 pm
Nonetheless, there are several challenges that must be addressed prior to widespread adoption of phage therapy. In this section, the authors consider various strategies of phage formulation ...
via Bing News